Telegram-
Loading indices

KOSPI · 302440

SK bioscience

Market cap₩2.89T
PERN/A
PBR1.65×
Foreign ownership6.27%
Avg. analyst target₩46,000

Pension summary

as of Oct 19
streak32-day net sell
5D-₩970M
20D-₩4.9B
60D-₩8.0B
Foreign 20D+₩4.3B
Inst. 20D-₩2.0B

Pension daily net buy

-

Cumulative net buying by investor

-
선택 기간의 net buy Total · ₩100M
DateClosePension fundsForeignInstitutionsRetail
10/1936,800-₩290M+₩1.1B-₩10M-₩1.1B
10/1636,100-₩250M+₩1.3B-₩350M-₩990M
10/1535,150-₩180M-₩430M+₩770M-₩340M
10/1436,300-₩150M+₩180M-₩100M-₩70M
10/1336,350-₩100M+₩780M+₩420M-₩1.2B
10/1236,400-₩90M-₩270M+₩420M-₩150M
10/836,850-₩240M+₩1.1B-₩1.4B+₩210M
10/737,750-₩250M+₩80M-₩260M+₩180M
10/637,750-₩260M+₩440M-₩20M-₩450M
10/236,500-₩230M-₩310M-₩60M+₩290M

Discussion

Google-verified members · return since posting
0/300

  1. Loading

Pension cost basis

Oct 19 Close · positions since 2024
Pension cost basis46,660
Price vs. cost-21.1%
Holding value₩8.0B
Last 20 days-₩4.9B
All pension cost data →

세력 매집

last 60 trading days · Oct 19
Foreign 60D+₩13.0B
Pension funds 60D−₩7.9B
세력 Avg. cost36,360
vs. cost Close+1.2%

Foreign+Pension funds Total 시총의 +0.2%, 60D price 폭 18%·Chg +8.4%. 세력 Avg. cost net buy한 날의 Avg 매수단가로 낸 est.치예요.

세력 매집 구간 All →

Financial score

#480 of KOSPI 500
32.2/100
  • Value5.4
  • Quality3
  • Growth1.5
  • Financials9.5
  • Risk12.8
소외
All stock scores →

ETF

ETFs holding it in their top 10 · recent changes

10/08 이후 큰 ETF 변화는 없어요

All ETF index changes →

Recent filings

DART
  1. Loading

Broker price targets

Recent 1Y
Avg55,000
High55,000
Low55,000
BrokerRatingTargetvs priorDate
Daishin Securities이OONeutral55,000▲28%25.11.04

Recent reports

  1. 수익성 회복세 지속, PCV21 임상 순항중Daishin Securities · 11/04
  2. CDMO 자회사 조기 턴어라운드 진입Daishin Securities · 05/08
  3. 차근차근 나아가는 중Daishin Securities · 10/29

Latest report per broker in the past year · Source: Naver Securities Research, Hankyung Consensus · Analyst names masked

Same sector

  1. Samsung Biologics
  2. Celltrion
  3. SAMSUNG EPIS HOLDINGS
  4. Yuhan
  5. SK Biopharm
  6. HanmiPharm

SK bioscience summary

SK bioscience (302440). Pension funds: -₩4.9B over the last 20 trading days; 32-day net selling streak. Market cap ₩2.89T, PER N/A, PBR 1.65×. Avg. analyst target ₩46,000. Pension flows are based on Korea Exchange investor statistics, for reference only.